Home Treatment in Australia: Safer, Cheaper, Better
HHD provides better care while saving as much as $60 million dollars in New South Wales alone—as well as reducing the mortality rate by as much as 20%, said researcher Andrew Page.
Read the full article » | Posted 03-10-2016
Related Articles
- FDA Class I Recalls of Dialysis Products for Potential Risk of Serious Injury or Death Posted 05-09-2024
- New Partnership Will Bring Tablo to 33 States Where US Renal Care has Clinics Posted 05-09-2024
- Tablo-maker Outset Joined the ANNA’s Partnership Advisory Council Posted 05-09-2024
- Watch an Interview with Dialysis Nurse Towanda Maker Posted 04-12-2024